Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Capricor Therapeutics (CAPR) Return on Assets (2016 - 2025)

Capricor Therapeutics (CAPR) has 15 years of Return on Assets data on record, last reported at 0.63% in Q3 2025.

  • For Q3 2025, Return on Assets fell 11.0% year-over-year to 0.63%; the TTM value through Sep 2025 reached 0.63%, down 11.0%, while the annual FY2024 figure was 0.35%, 6.0% up from the prior year.
  • Return on Assets reached 0.63% in Q3 2025 per CAPR's latest filing, down from 0.49% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.31% in Q4 2024 and bottomed at 0.7% in Q3 2023.
  • Average Return on Assets over 5 years is 0.5%, with a median of 0.49% recorded in 2025.
  • Peak YoY movement for Return on Assets: fell -20bps in 2023, then increased 18bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.49% in 2021, then fell by -13bps to 0.56% in 2022, then increased by 17bps to 0.47% in 2023, then surged by 34bps to 0.31% in 2024, then crashed by -105bps to 0.63% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.63% in Q3 2025, 0.49% in Q2 2025, and 0.34% in Q1 2025.